相似文献
1
[Yes, simplify antiretroviral treatments, but not at a significant price!].
Med Mal Infect. 2005 Apr;35 Suppl 1:S11-4. doi: 10.1016/s0399-077x(05)80178-7.
2
Once-daily therapies.
J HIV Ther. 2003 Feb;8(1):7-11.
3
New antiretroviral drugs and approaches to HIV treatment.
AIDS. 2003;17 Suppl 4:S85-96. doi: 10.1097/00002030-200317004-00010.
4
Therapeutic drug monitoring: pharmacologic considerations for antiretroviral drugs.
Curr HIV/AIDS Rep. 2005 Jun;2(2):61-7. doi: 10.1007/s11904-005-0020-8.
5
Drugs for HIV Infection.
Treat Guidel Med Lett. 2009 Feb;7(78):11-22.
6
Adherence to first-line antiretroviral regimens in Rwanda.
J Acquir Immune Defic Syndr. 2005 Sep 1;40(1):113-4. doi: 10.1097/01.qai.0000176590.68430.59.
7
If we can't get what we want, can we get what we need? optimizing use of antiretroviral therapy in the current era.
Ann Intern Med. 2011 Apr 19;154(8):563-5. doi: 10.7326/0003-4819-154-8-201104190-00009.
8
Selective drug taking during combination antiretroviral therapy.
J Acquir Immune Defic Syndr. 2007 Apr 1;44(4):490-1. doi: 10.1097/QAI.0b013e318031d033.
9
[Once-a-day highly active antiretroviral therapy. Present or future?].
Med Clin (Barc). 2003 Sep 13;121(8):304-9. doi: 10.1016/s0025-7753(03)73925-6.
10
Monitoring of antiretroviral therapy in low-resource settings.
Lancet. 2008 Jul 26;372(9635):288-9; author reply 289. doi: 10.1016/S0140-6736(08)61103-4.
Zotero 插件